Clinical trial
ArmeoSenso - Rewarding vs. Non-rewarding Therapy of Patients With Arm Impairments Based on Wearable Movement Sensors
NCT02257125 is registered in ClinicalTrials.gov with Cereneo AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ArmeoSenso - Rewarding vs. Non-rewarding Therapy of Patients With Arm Impairments Based on Wearable Movement Sensors
- Lead sponsor
- Cereneo AG
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 27, 2015
- Completion date
- October 28, 2019
- Enrollment
- 38 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.